NOSTRAND ROBERT L VAN Insider Trading $OSIP OSI PHARMACEUTICALS INC
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for NOSTRAND ROBERT L VAN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of NOSTRAND ROBERT L VAN. NOSTRAND ROBERT L VAN is VP, & Chief Financial Officer in OSI PHARMACEUTICALS INC ($OSIP) and Director in METABOLIX, INC. ($MBLX) and in ACHILLION PHARMACEUTICALS INC ($ACHN) and Director in ACHILLION PHARMACEUTICALS INC ($ACHN) and Director in SELLAS Life Sciences Group, Inc. ($GALE) and Director in Enumeral Biomedical Holdings, Inc. ($ENUM) and Director in Intra-Cellular Therapies, Inc. ($ITCI).
NOSTRAND ROBERT L VAN in OSI PHARMACEUTICALS INC
Trading Symbol: OSIPIndustry: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
Position of NOSTRAND ROBERT L VAN: VP, & Chief Financial Officer
Holdings: 4,899 shares
Latest Transaction: May 03 2005
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of NOSTRAND ROBERT L VAN in OSI PHARMACEUTICALS INC
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ACHN, ENUM, ITCI, OSIP, SLS, MBLX
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 03 2005 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Option Exercise | M | 21.55 | 1,250 | 26,938 | 8,955 | |
May 03 2005 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 47.50 | 300 | 14,250 | 4,899 | 5.2 K to 4.9 K (-5.77 %) |
May 03 2005 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 47.49 | 200 | 9,498 | 5,199 | 5.4 K to 5.2 K (-3.70 %) |
May 03 2005 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 47.42 | 200 | 9,484 | 5,399 | 5.6 K to 5.4 K (-3.57 %) |
May 03 2005 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 47.41 | 100 | 4,741 | 5,599 | 5.7 K to 5.6 K (-1.75 %) |
May 03 2005 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 47.39 | 300 | 14,217 | 5,699 | 6 K to 5.7 K (-5.00 %) |
May 03 2005 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 47.38 | 150 | 7,107 | 5,999 | 6.1 K to 6 K (-2.44 %) |
May 03 2005 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Buy | M | 21.55 | 1,250 | 26,938 | 6,149 | 4.9 K to 6.1 K (+25.52 %) |
Apr 19 2005 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Option Exercise | M | 21.55 | 1,000 | 21,550 | 10,205 | |
Apr 19 2005 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 50.00 | 1,000 | 50,000 | 4,899 | 5.9 K to 4.9 K (-16.95 %) |
Apr 19 2005 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Buy | M | 21.55 | 1,000 | 21,550 | 5,899 | 4.9 K to 5.9 K (+20.41 %) |
Apr 07 2005 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Option Exercise | M | 21.55 | 1,250 | 26,938 | 11,205 | |
Apr 07 2005 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 45.00 | 1,250 | 56,250 | 4,899 | 6.1 K to 4.9 K (-20.33 %) |
Apr 07 2005 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Buy | M | 21.55 | 1,250 | 26,938 | 6,149 | 4.9 K to 6.1 K (+25.52 %) |
Mar 03 2005 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Option Exercise | M | 21.55 | 2,250 | 48,488 | 12,455 | |
Mar 03 2005 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 54.70 | 28 | 1,532 | 4,899 | 4.9 K to 4.9 K (-0.57 %) |
Mar 03 2005 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 54.50 | 16 | 872 | 4,927 | 4.9 K to 4.9 K (-0.32 %) |
Mar 03 2005 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 54.31 | 16 | 869 | 4,943 | 5 K to 4.9 K (-0.32 %) |
Mar 03 2005 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 54.30 | 31 | 1,683 | 4,959 | 5 K to 5 K (-0.62 %) |
Mar 03 2005 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 54.12 | 127 | 6,873 | 4,990 | 5.1 K to 5 K (-2.48 %) |
Mar 03 2005 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 54.11 | 16 | 866 | 5,117 | 5.1 K to 5.1 K (-0.31 %) |
Mar 03 2005 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 54.10 | 607 | 32,839 | 5,133 | 5.7 K to 5.1 K (-10.57 %) |
Mar 03 2005 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 54.05 | 106 | 5,729 | 5,740 | 5.8 K to 5.7 K (-1.81 %) |
Mar 03 2005 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 54.02 | 16 | 864 | 5,846 | 5.9 K to 5.8 K (-0.27 %) |
Mar 03 2005 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 54.01 | 48 | 2,592 | 5,862 | 5.9 K to 5.9 K (-0.81 %) |
Mar 03 2005 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 54.00 | 207 | 11,178 | 5,910 | 6.1 K to 5.9 K (-3.38 %) |
Mar 03 2005 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 53.94 | 119 | 6,419 | 6,117 | 6.2 K to 6.1 K (-1.91 %) |
Mar 03 2005 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 53.91 | 16 | 863 | 6,236 | 6.3 K to 6.2 K (-0.26 %) |
Mar 03 2005 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 53.86 | 32 | 1,724 | 6,252 | 6.3 K to 6.3 K (-0.51 %) |
Mar 03 2005 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 53.84 | 318 | 17,121 | 6,284 | 6.6 K to 6.3 K (-4.82 %) |
Mar 03 2005 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 53.83 | 347 | 18,679 | 6,602 | 6.9 K to 6.6 K (-4.99 %) |
Mar 03 2005 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 53.82 | 64 | 3,444 | 6,949 | 7 K to 6.9 K (-0.91 %) |
Mar 03 2005 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 53.81 | 16 | 861 | 7,013 | 7 K to 7 K (-0.23 %) |
Mar 03 2005 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 53.80 | 32 | 1,722 | 7,029 | 7.1 K to 7 K (-0.45 %) |
Mar 03 2005 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 53.76 | 88 | 4,731 | 7,061 | 7.1 K to 7.1 K (-1.23 %) |
Mar 03 2005 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Buy | M | 21.55 | 2,250 | 48,488 | 7,149 | 4.9 K to 7.1 K (+45.93 %) |
Feb 03 2005 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Option Exercise | M | 21.55 | 2,095 | 45,147 | 14,705 | |
Feb 03 2005 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Option Exercise | M | 7.09 | 155 | 1,100 | 0 | |
Feb 03 2005 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 65.16 | 1,044 | 68,027 | 4,899 | 5.9 K to 4.9 K (-17.57 %) |
Feb 03 2005 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 65.15 | 301 | 19,610 | 5,943 | 6.2 K to 5.9 K (-4.82 %) |
Feb 03 2005 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 65.10 | 604 | 39,320 | 6,244 | 6.8 K to 6.2 K (-8.82 %) |
Feb 03 2005 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 65.00 | 301 | 19,565 | 6,848 | 7.1 K to 6.8 K (-4.21 %) |
Feb 03 2005 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Buy | M | 21.55 | 2,095 | 45,147 | 7,149 | 5.1 K to 7.1 K (+41.45 %) |
Feb 03 2005 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Buy | M | 7.09 | 155 | 1,100 | 5,054 | 4.9 K to 5.1 K (+3.16 %) |
Jan 05 2005 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Option Exercise | M | 7.09 | 5,500 | 39,017 | 155 | |
Jan 05 2005 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 74.60 | 28 | 2,089 | 4,899 | 4.9 K to 4.9 K (-0.57 %) |
Jan 05 2005 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 74.50 | 138 | 10,281 | 4,927 | 5.1 K to 4.9 K (-2.72 %) |
Jan 05 2005 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 74.47 | 1,805 | 134,418 | 5,065 | 6.9 K to 5.1 K (-26.27 %) |
Jan 05 2005 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 74.43 | 14 | 1,042 | 6,870 | 6.9 K to 6.9 K (-0.20 %) |
Jan 05 2005 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 74.42 | 96 | 7,144 | 6,884 | 7 K to 6.9 K (-1.38 %) |
Jan 05 2005 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 74.41 | 69 | 5,134 | 6,980 | 7 K to 7 K (-0.98 %) |
Jan 05 2005 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 74.40 | 81 | 6,026 | 7,049 | 7.1 K to 7 K (-1.14 %) |
Jan 05 2005 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 74.17 | 14 | 1,038 | 7,130 | 7.1 K to 7.1 K (-0.20 %) |
Jan 05 2005 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 74.10 | 28 | 2,075 | 7,144 | 7.2 K to 7.1 K (-0.39 %) |
Jan 05 2005 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 74.05 | 110 | 8,146 | 7,172 | 7.3 K to 7.2 K (-1.51 %) |
Jan 05 2005 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 73.95 | 345 | 25,513 | 7,282 | 7.6 K to 7.3 K (-4.52 %) |
Jan 05 2005 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 73.65 | 689 | 50,745 | 7,627 | 8.3 K to 7.6 K (-8.29 %) |
Jan 05 2005 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 73.62 | 14 | 1,031 | 8,316 | 8.3 K to 8.3 K (-0.17 %) |
Jan 05 2005 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 73.60 | 41 | 3,018 | 8,330 | 8.4 K to 8.3 K (-0.49 %) |
Jan 05 2005 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 73.53 | 1,408 | 103,530 | 8,371 | 9.8 K to 8.4 K (-14.40 %) |
Jan 05 2005 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 73.52 | 620 | 45,582 | 9,779 | 10.4 K to 9.8 K (-5.96 %) |
Jan 05 2005 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Buy | M | 7.09 | 5,500 | 39,017 | 10,399 | 4.9 K to 10.4 K (+112.27 %) |
Dec 03 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Option Exercise | M | 7.09 | 2,750 | 19,509 | 5,655 | |
Dec 03 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 48.74 | 16 | 780 | 4,899 | 4.9 K to 4.9 K (-0.33 %) |
Dec 03 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 48.66 | 78 | 3,795 | 4,915 | 5 K to 4.9 K (-1.56 %) |
Dec 03 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 48.65 | 280 | 13,622 | 4,993 | 5.3 K to 5 K (-5.31 %) |
Dec 03 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 48.64 | 16 | 778 | 5,273 | 5.3 K to 5.3 K (-0.30 %) |
Dec 03 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 48.60 | 15 | 729 | 5,289 | 5.3 K to 5.3 K (-0.28 %) |
Dec 03 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 48.58 | 156 | 7,578 | 5,304 | 5.5 K to 5.3 K (-2.86 %) |
Dec 03 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 48.57 | 280 | 13,600 | 5,260 | 5.5 K to 5.3 K (-5.05 %) |
Dec 03 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 48.50 | 341 | 16,539 | 5,740 | 6.1 K to 5.7 K (-5.61 %) |
Dec 03 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 48.45 | 16 | 775 | 6,081 | 6.1 K to 6.1 K (-0.26 %) |
Dec 03 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 48.41 | 31 | 1,501 | 6,097 | 6.1 K to 6.1 K (-0.51 %) |
Dec 03 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 48.40 | 140 | 6,776 | 6,128 | 6.3 K to 6.1 K (-2.23 %) |
Dec 03 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 48.37 | 264 | 12,770 | 6,268 | 6.5 K to 6.3 K (-4.04 %) |
Dec 03 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 48.29 | 121 | 5,843 | 6,532 | 6.7 K to 6.5 K (-1.82 %) |
Dec 03 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 48.03 | 31 | 1,489 | 6,653 | 6.7 K to 6.7 K (-0.46 %) |
Dec 03 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 48.02 | 140 | 6,723 | 6,684 | 6.8 K to 6.7 K (-2.05 %) |
Dec 03 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 48.01 | 187 | 8,978 | 6,824 | 7 K to 6.8 K (-2.67 %) |
Dec 03 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 48.00 | 140 | 6,720 | 7,011 | 7.2 K to 7 K (-1.96 %) |
Dec 03 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 47.99 | 78 | 3,743 | 7,151 | 7.2 K to 7.2 K (-1.08 %) |
Dec 03 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 47.98 | 140 | 6,717 | 7,229 | 7.4 K to 7.2 K (-1.90 %) |
Dec 03 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 47.97 | 233 | 11,177 | 7,369 | 7.6 K to 7.4 K (-3.06 %) |
Dec 03 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 47.95 | 47 | 2,254 | 7,602 | 7.6 K to 7.6 K (-0.61 %) |
Dec 03 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Buy | M | 7.09 | 2,750 | 19,509 | 7,649 | 4.9 K to 7.6 K (+56.13 %) |
Dec 03 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Grant | A | 58.16 | 10 | 582 | 4,899 | 4.9 K to 4.9 K (+0.20 %) |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Option Exercise | M | 7.09 | 2,750 | 19,509 | 8,405 | |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 64.83 | 171 | 11,086 | 4,766 | 4.9 K to 4.8 K (-3.46 %) |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 64.60 | 181 | 11,693 | 4,937 | 5.1 K to 4.9 K (-3.54 %) |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 64.54 | 19 | 1,226 | 5,118 | 5.1 K to 5.1 K (-0.37 %) |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 64.53 | 19 | 1,226 | 5,137 | 5.2 K to 5.1 K (-0.37 %) |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 64.52 | 75 | 4,839 | 5,156 | 5.2 K to 5.2 K (-1.43 %) |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 64.49 | 48 | 3,096 | 5,231 | 5.3 K to 5.2 K (-0.91 %) |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 64.40 | 38 | 2,447 | 5,279 | 5.3 K to 5.3 K (-0.71 %) |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 64.32 | 29 | 1,865 | 5,317 | 5.3 K to 5.3 K (-0.54 %) |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 64.31 | 18 | 1,158 | 5,346 | 5.4 K to 5.3 K (-0.34 %) |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 64.30 | 722 | 46,425 | 5,364 | 6.1 K to 5.4 K (-11.86 %) |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 64.25 | 1,192 | 76,586 | 6,086 | 7.3 K to 6.1 K (-16.38 %) |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 64.21 | 48 | 3,082 | 7,278 | 7.3 K to 7.3 K (-0.66 %) |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 64.20 | 190 | 12,198 | 7,326 | 7.5 K to 7.3 K (-2.53 %) |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Buy | M | 7.09 | 2,750 | 19,509 | 7,516 | 4.8 K to 7.5 K (+57.70 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Option Exercise | M | 7.09 | 2,750 | 19,509 | 11,155 | |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 61.83 | 111 | 6,863 | 4,766 | 4.9 K to 4.8 K (-2.28 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 61.75 | 25 | 1,544 | 4,877 | 4.9 K to 4.9 K (-0.51 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 61.60 | 197 | 12,135 | 4,902 | 5.1 K to 4.9 K (-3.86 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 61.55 | 99 | 6,093 | 5,099 | 5.2 K to 5.1 K (-1.90 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 61.30 | 49 | 3,004 | 5,198 | 5.2 K to 5.2 K (-0.93 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 61.25 | 12 | 735 | 5,247 | 5.3 K to 5.2 K (-0.23 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 61.19 | 12 | 734 | 5,259 | 5.3 K to 5.3 K (-0.23 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 61.18 | 49 | 2,998 | 5,271 | 5.3 K to 5.3 K (-0.92 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 61.11 | 12 | 733 | 5,320 | 5.3 K to 5.3 K (-0.23 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 61.10 | 320 | 19,552 | 5,332 | 5.7 K to 5.3 K (-5.66 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 61.09 | 37 | 2,260 | 5,652 | 5.7 K to 5.7 K (-0.65 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 61.07 | 49 | 2,992 | 5,698 | 5.7 K to 5.7 K (-0.85 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 61.05 | 37 | 2,259 | 5,738 | 5.8 K to 5.7 K (-0.64 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 61.00 | 287 | 17,507 | 5,775 | 6.1 K to 5.8 K (-4.73 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 60.96 | 1,231 | 75,042 | 6,062 | 7.3 K to 6.1 K (-16.88 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 60.83 | 12 | 730 | 7,293 | 7.3 K to 7.3 K (-0.16 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 60.81 | 25 | 1,520 | 7,305 | 7.3 K to 7.3 K (-0.34 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 60.80 | 62 | 3,770 | 7,330 | 7.4 K to 7.3 K (-0.84 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 60.78 | 12 | 729 | 7,392 | 7.4 K to 7.4 K (-0.16 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 60.77 | 25 | 1,519 | 7,404 | 7.4 K to 7.4 K (-0.34 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 60.76 | 38 | 2,309 | 7,429 | 7.5 K to 7.4 K (-0.51 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 60.75 | 49 | 2,977 | 7,467 | 7.5 K to 7.5 K (-0.65 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Buy | M | 7.09 | 2,750 | 19,509 | 7,516 | 4.8 K to 7.5 K (+57.70 %) |
Sep 02 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Option Exercise | M | 7.09 | 2,750 | 19,509 | 13,905 | |
Sep 02 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 59.45 | 230 | 13,674 | 4,766 | 5 K to 4.8 K (-4.60 %) |
Sep 02 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 59.40 | 204 | 12,118 | 4,996 | 5.2 K to 5 K (-3.92 %) |
Sep 02 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 59.18 | 370 | 21,897 | 5,200 | 5.6 K to 5.2 K (-6.64 %) |
Sep 02 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 59.16 | 125 | 7,395 | 5,570 | 5.7 K to 5.6 K (-2.19 %) |
Sep 02 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 59.12 | 1,035 | 61,189 | 5,695 | 6.7 K to 5.7 K (-15.38 %) |
Sep 02 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 59.02 | 320 | 18,886 | 6,730 | 7.1 K to 6.7 K (-4.54 %) |
Sep 02 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 59.01 | 12 | 708 | 7,050 | 7.1 K to 7.1 K (-0.17 %) |
Sep 02 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 59.00 | 377 | 22,243 | 7,062 | 7.4 K to 7.1 K (-5.07 %) |
Sep 02 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 58.99 | 26 | 1,534 | 7,439 | 7.5 K to 7.4 K (-0.35 %) |
Sep 02 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 58.98 | 51 | 3,008 | 7,465 | 7.5 K to 7.5 K (-0.68 %) |
Sep 02 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Buy | M | 7.09 | 2,750 | 19,509 | 7,516 | 4.8 K to 7.5 K (+57.70 %) |
Aug 04 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Option Exercise | M | 7.09 | 345 | 2,447 | 16,655 | |
Aug 04 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Option Exercise | M | 9.00 | 2,405 | 21,645 | 0 | |
Aug 04 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 58.61 | 238 | 13,949 | 4,766 | 5 K to 4.8 K (-4.76 %) |
Aug 04 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 58.52 | 36 | 2,107 | 5,004 | 5 K to 5 K (-0.71 %) |
Aug 04 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 58.50 | 273 | 15,971 | 5,040 | 5.3 K to 5 K (-5.14 %) |
Aug 04 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 58.33 | 670 | 39,081 | 5,313 | 6 K to 5.3 K (-11.20 %) |
Aug 04 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 58.24 | 24 | 1,398 | 5,983 | 6 K to 6 K (-0.40 %) |
Aug 04 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 58.23 | 36 | 2,096 | 6,007 | 6 K to 6 K (-0.60 %) |
Aug 04 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 58.22 | 24 | 1,397 | 6,043 | 6.1 K to 6 K (-0.40 %) |
Aug 04 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 58.21 | 12 | 699 | 6,067 | 6.1 K to 6.1 K (-0.20 %) |
Aug 04 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 58.20 | 416 | 24,211 | 6,079 | 6.5 K to 6.1 K (-6.40 %) |
Aug 04 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 58.17 | 12 | 698 | 6,495 | 6.5 K to 6.5 K (-0.18 %) |
Aug 04 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 58.16 | 60 | 3,490 | 6,507 | 6.6 K to 6.5 K (-0.91 %) |